Single dose of Covid vaccine sufficient for already infected people: Study

The study was designed to assess the immunological memory response in all those patients.

Topics
Coronavirus | Coronavirus Tests | Coronavirus Vaccine

Press Trust of India  |  Hyderabad 

Glaxo and Sanofi plan to start advanced trials in coming weeks, with multiple formulations of the vaccine to better protect against variants. (Photo: Bloomberg)
Covid-19 vaccine | File photo

A single dose of COVID-19 vaccine is sufficient for an infected person as there was a greater antibody response when compared with those who have had no prior infection, according to a study released by AIG Hospitals on Monday.

The city-based AIG Hospitals recently published a study conducted on 260 healthcare workers, who got vaccinated between January 16 and February 5, in the International Journal of Infectious Diseases (a peer-reviewed journal).

The study was designed to assess the immunological memory response in all those patients.

All patients were given the Covishield vaccine.

The study also said Memory T-cell responses elicited by a single dose of vaccine were significantly higher in the previously infected group compared with those who had no prior infection.

Commenting on the impact that this study can have on the overall vaccine administration strategy, Dr. D Nageshwar Reddy, Chairman, AIG Hospitals, and one of the co-authors of the study, said the results show that people who got infected with COVID-19 need not take two doses of vaccine as a single dose can develop robust antibody and memory cell response at par with two-doses for those who didnt get the infection.

This will significantly help at a time when theres a shortage of vaccine in the country and more people can be covered using the saved doses, Dr Reddy said.

Once the requisite number of people are vaccinated for achieving herd immunity, these patients who got infected and received only one dose can take the second dose of the vaccine, he further said.

At this point, all our strategies should be directed at the widespread distribution of available vaccines and to include the maximum number of people at least with a single dose, Dr Reddy added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus
First Published: Mon, June 14 2021. 19:45 IST
RECOMMENDED FOR YOU